Pages that link to "Q39582185"

The following pages link to Effects of AZD1152, a selective Aurora B kinase inhibitor, on Burkitt's and Hodgkin's lymphomas. (Q39582185):

Displaying 12 items.

• Reed-Sternberg cells form by abscission failure in the presence of functional Aurora B kinase (Q27309002) (← links)
• Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma (Q35819646) (← links)
• The p38 MAPK inhibitor BIRB796 enhances the antitumor effects of VX680 in cervical cancer (Q37013275) (← links)
• The potential role of Aurora kinase inhibitors in haematological malignancies (Q37167047) (← links)
• Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene (Q37216463) (← links)
• Loss of the proteins Bak and Bax prevents apoptosis mediated by histone deacetylase inhibitors. (Q37505528) (← links)
• ENMD-2076 for hematological malignancies (Q37991379) (← links)
• Quinazoline derivatives as potential anticancer agents: a patent review (2007 - 2010). (Q37992086) (← links)
• The Aurora kinase inhibitors in cancer research and therapy (Q38756932) (← links)
• Aurora B inhibitor barasertib and cytarabine exert a greater-than-additive cytotoxicity in acute myeloid leukemia cells (Q39171321) (← links)
• Noradrenaline goes nuclear: epigenetic modifications during long-lasting synaptic potentiation triggered by activation of β-adrenergic receptors (Q50554777) (← links)
• Aurora B kinase in Hodgkin lymphoma: immunohistochemical pattern of expression in neoplastic Hodgkin and Reed-Sternberg cells. (Q53076735) (← links)